about
Prescribing azithromycinSevere thrombocytopenia in a child with typhoid fever: a case report.Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory.Prototheca wickerhamii mimicking yeast: a cautionary tale.Rapid microscopy and use of vital dyes: potential to determine viability of Cryptococcus neoformans in the clinical laboratory.Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013-2014.Cryptococcus gattii infections: contemporary aspects of epidemiology, clinical manifestations and management of infection.A Pilot Study of a Computerized Decision Support System to Detect Invasive Fungal Infection in Pediatric Hematology/Oncology Patients.Changing epidemiology of candidaemia in Australia.Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children.An infant with meningococcal arthritis of the hip.Multiresistant E. coli urine infections in children: a case-control study.Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: A systematic review.Persistent Gram-Negative Neurosurgical Meningitis in a Neonate, Successfully Treated With Intraventricular Colistin: Case Report and Review of the Literature.A 68-year-old type 2 diabetic man of Korean ethnicity with fever, abdominal pain, and right eye visual disturbance.Sepsis-like disease in infants due to human parechovirus type 3 during an outbreak in Australia.Outcomes of multisite antimicrobial stewardship programme implementation with a shared clinical decision support system.Changing epidemiology of candidaemia in Australia.Targeting Staphylococcus aureus in Pediatric Surviving Sepsis Bundles-Reply.Epidemiology of Late and Very Late Onset Group B Streptococcal Disease: Fifteen-Year Experience From Two Australian Tertiary Pediatric Facilities.Successful treatment of cutaneous protothecosis with liposomal amphotericin and oral itraconazole.Australia-wide point prevalence survey of the use and appropriateness of antimicrobial prescribing for children in hospital.High prevalence of developmental concern amongst infants at 12 months following hospitalised parechovirus infection.Reply to “Fatal Prototheca wickerhamii Bloodstream Infection in a Cardiac Allograft Recipient”†.Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.Pandemic (H1N1) 2009 influenza with neurological complications diagnosed using specific serology with the haemagglutinin inhibition assayAhead of consensus: a paediatric antifungal prophylaxis censusThe Impact of an Infectious Diseases Consultation on Antimicrobial PrescribingAcute kidney injury due to crystalluria following acute valacyclovir overdoseRoyal Australasian College of Physicians' advanced training outside of Australia and New Zealand: trainees' and supervisors' perspectivesBezold's abscess: a serious complication of otitis mediaGetting to the bones of the matterReply to EisenhutLocally acquired severe non-O1 and non-O139 Vibrio cholerae infection associated with ingestion of imported seafoodAntibody responses in infants after antenatal maternal pertussis vaccinationAntibiotic prescribing in neonatal sepsis: an Australian nationwide surveyAntibiotic appropriateness and guideline adherence in hospitalized children: results of a nationwide study
P50
Q26773297-B5BDD0FD-30CC-4E19-AB57-52082DC86161Q33437279-99A2A691-4535-4038-9C79-AB63E8789BFDQ34482498-F20A629F-AFD5-4869-9730-0E33CB0DEAAAQ35139820-CC66B8A1-3EB6-4DD0-8D15-C036C95CD4D3Q35549784-7B803AE9-74B7-4CA8-942D-BF0F69403D62Q35780224-9645BE28-FF98-4772-807C-AD554696AA34Q38165199-710BFD7E-AE56-4F64-9570-134F5A9FCA33Q38567637-538023CD-8806-4D55-98F4-CA96D828BF9EQ38863487-897DEF33-F81F-4EAA-B551-71C9D9E48FA1Q38870252-A639D40D-695B-4E1E-A63E-FC4AB860FA4CQ39481813-F13FE36A-2CB5-4743-9C5F-AEDA6B550976Q39879988-1844DED7-5DAE-4E65-93BC-2BB94E4F99D8Q40050490-23596DAE-52A1-4A7B-A407-BBEE8871393CQ40055963-E6E7C517-31FD-418D-B221-5177FD51BE24Q40079569-791AA09E-4A12-4D07-9231-54D81D9F914DQ40172677-1B23609F-4068-42AE-8C37-AE8392281F42Q40187568-C624E463-9B4F-4034-B583-95646B9085BCQ40282031-E717E404-52EA-42A3-A82A-0B72A3E65BEAQ40330819-27280165-BAD5-4DB3-B04E-442507053854Q40361535-61618431-1B3E-4624-99A4-71BD7317EB83Q40504000-A64AD9F0-6554-44A6-91E6-976D3716FCF5Q40535820-A8B18FA3-DF52-42EC-BAE6-FDCCDE5FD794Q41606037-F5865478-2FE3-453F-BF6A-654007160521Q41928103-AB80DC21-CA68-4EB9-83C0-57E27B2F6BFDQ45820845-24052145-9A62-42A0-B6EE-1376199EAD6BQ53393992-146F797D-419F-447C-8F2C-221B31DDA621Q57103997-8FA9414E-CDAD-45E1-97C3-E70567293F6AQ60231315-027872B8-77A0-4EBF-BF02-8051DC456012Q60231316-30FA1CEB-9CF2-4DFF-A95A-2F7CE308D7B2Q83412127-F1B146CF-C1BB-4ED3-B1CF-B1D70192DDE1Q84498528-6F002F2A-B8B9-42A5-BE8C-76C8F0BC3272Q84554883-20AFD7D1-F1E7-45E3-A3D7-18284D0B96CAQ85189513-66BCBE9A-05E0-40C1-A119-BA54B09CEB04Q86995222-8F7DABE6-407F-4121-A03B-2C7E23279071Q87049362-7144AEA5-241B-434F-8486-4773E45C1E45Q88150133-67F34757-D122-4211-B446-2DFFC737D54CQ90783104-6E52F515-7E86-41A4-945E-1121059FFF7DQ91162804-42AAC63E-025F-4B15-9CC5-90AECA062360
P50
description
investigador
@es
researcher
@en
name
Brendan J McMullan
@en
type
label
Brendan J McMullan
@en
prefLabel
Brendan J McMullan
@en
P31
P496
0000-0001-5144-3416